The city of Birmingham, Alabama, currently has 1 active clinical trials seeking participants for Crohn's Disease research studies.
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
06/18/2024
Locations: University of Alabama Liver Center, Birmingham, Alabama
Conditions: Crohn's Disease